» Articles » PMID: 26783414

Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats

Overview
Publisher Wiley
Date 2016 Jan 20
PMID 26783414
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigated whether central activation of angiotensin II type 2 receptor (AT2-R) attenuates deoxycorticosterone acetate (DOCA)/NaCl-induced hypertension in intact and ovariectomized (OVX) female rats and whether female sex hormone status has influence on the effects of AT2-R activation. DOCA/NaCl elicited a greater increase in blood pressure in OVX females than that in intact females. Central infusion of compound 21, a specific AT2-R agonist, abolished DOCA/NaCl pressor effect in intact females, whereas same treatment in OVX females produced an inhibitory effect. Real-time RT-PCR analysis revealed that DOCA/NaCl enhanced the mRNA expression of hypertensive components including AT1-R, ACE-1, and TNF-α in the paraventricular nucleus of hypothalamus in both intact and OVX females. However, the mRNA expressions of antihypertensive components such as AT2-R, ACE-2, and IL-10 were increased only in intact females. Central AT2-R agonist reversed the changes in the hypertensive components in all females, while this agonist further upregulated the expression of ACE2 and IL-10 in intact females, but only IL-10 in OVX females. These results indicate that brain AT2-R activation plays an inhibitory role in the development of DOCA/NaCl-induced hypertension in females. This beneficial effect of AT2-R activation involves regulation of renin-angiotensin system and proinflammatory cytokines.

Citing Articles

COVID-19 and thyroid function: What do we know so far?.

Rossetti C, Cazarin J, Hecht F, de Lima Beltrao F, Freitas Ferreira A, Fortunato R Front Endocrinol (Lausanne). 2023; 13:1041676.

PMID: 36601011 PMC: 9806267. DOI: 10.3389/fendo.2022.1041676.


Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic.

Chen H, Peng J, Wang T, Wen J, Chen S, Huang Y Biochem Pharmacol. 2022; 208:115370.

PMID: 36481346 PMC: 9721294. DOI: 10.1016/j.bcp.2022.115370.


Effect of the renin-angiotensin system on the exacerbation of adrenal glucocorticoid steroidogenesis in diabetic mice: Role of angiotensin-II type 2 receptor.

Chaves A, Magalhaes N, Insuela D, Rodrigues e Silva P, Martins M, Carvalho V Front Endocrinol (Lausanne). 2022; 13:1040040.

PMID: 36465619 PMC: 9712183. DOI: 10.3389/fendo.2022.1040040.


Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation in Attenuating Hypertension via Its Modulatory Activities on the Intrarenal Renin-Angiotensin System in Spontaneously Hypertensive Rats.

Parn K, Ling W, Chin J, Lee S Nutrients. 2022; 14(21).

PMID: 36364864 PMC: 9654342. DOI: 10.3390/nu14214605.


The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.

Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.

PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.


References
1.
Sriramula S, Cardinale J, Francis J . Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One. 2013; 8(5):e63847. PMC: 3655013. DOI: 10.1371/journal.pone.0063847. View

2.
Dhande I, Ma W, Hussain T . Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production. Hypertens Res. 2014; 38(1):21-9. PMC: 4898267. DOI: 10.1038/hr.2014.132. View

3.
Sabuhi R, Ali Q, Asghar M, Al-Zamily N, Hussain T . Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats. Am J Physiol Renal Physiol. 2011; 300(3):F700-6. PMC: 3064141. DOI: 10.1152/ajprenal.00616.2010. View

4.
McCarthy C, Widdop R, Denton K, Jones E . Update on the angiotensin AT(2) receptor. Curr Hypertens Rep. 2012; 15(1):25-30. DOI: 10.1007/s11906-012-0321-4. View

5.
Menk M, Graw J, Von Haefen C, Sifringer M, Schwaiberger D, Unger T . Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells. Inflammation. 2015; 38(4):1690-9. DOI: 10.1007/s10753-015-0146-9. View